Minimum follow-up of 4 years for ongoing patients with chronic-phase chronic myeloid leukemia (CP-CML) in a phase 1 trial of ponatinib Meeting Abstract

   


Authors: Talpaz, M.; Cortes, J. E.; Kantarjian, H. M.; Shah, N. P.; Bixby, D. L.; Flinn, I. W.; O'Hare, T. J.; Hu, S.; Rivera, V. M.; Clackson, T.; Conlan, M. G.; Haluska, F. G.; Druker, B. J.; Deininger, M. W.; Mauro, M. J.
Abstract Title: Minimum follow-up of 4 years for ongoing patients with chronic-phase chronic myeloid leukemia (CP-CML) in a phase 1 trial of ponatinib
Meeting Title: 20th Congress of the European Hematology Association (EHA)
Journal Title: Haematologica
Volume: 100
Issue: Suppl. 1
Meeting Dates: 2015 Jun 11-14
Meeting Location: Vienna, Austria
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2015-06-01
Start Page: 65
End Page: 66
Language: English
ACCESSION: WOS:000361204901139
PROVIDER: wos
PMCID: PMC4480587
Notes: Meeting Abstract: P237 -- Source: Wos